Abstract
Typical retinitis pigmentosa (RP) is defined as disease confined to eyeball. In some cases, mutations in known causal genes of RP result in the phenotype of RP and extraocular manifestations simultaneously. These genes are listed in Table 5.1. Moreover, there are systemic multi-organ disorders that show pigmentary retinopathy. Etiologies are variable including drug toxicity, infection, monogenic mutation. Some of these diseases have curable etiology or strategies to relieve or retard some conditions. Therefore, differential diagnosis is required to discriminate the cause of pigmentary retinopathy. A multidisciplinary approach is needed because systemic manifestations are quite heterogenous. In this chapter, inherited syndromic disorders showing typical pigmentary retinopathy will be described. Syndromic RP in this chapter includes Usher syndrome, ciliopathy, inborn errors of metabolism, and mitochondrial disorders (Table 5.2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Koenig R. Bardet-Biedl syndrome and Usher syndrome. Dev Ophthalmol. 2003;37:126–40. Available at: https://pubmed.ncbi.nlm.nih.gov/12876834/. Accessed 21 Dec 2020
Blanco-Kelly F, Jaijo T, Aller E, et al. Clinical aspects of usher syndrome and the USH2A gene in a cohort of 433 patients. JAMA Ophthalmol. 2015;133:157–64.
Fishman GA, Kumar A, Joseph ME, et al. Usher’s syndrome: ophthalmic and neuro-otologic findings suggesting genetic heterogeneity. Arch Ophthalmol. 1983;101:1367–74. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/6604514/. Accessed 21 Dec 2020
Piazza L, Fishman GA, Farber M, et al. Visual acuity loss in patients with Usher’s syndrome. Arch Ophthalmol. 1986;104:1336–9. Available at: https://pubmed.ncbi.nlm.nih.gov/3753284/. Accessed 21 Dec 2020
Ness SL, Ben-Yosef T, Bar-Lev A, et al. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J Med Genet. 2003;40:767–72. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/14569126/ Accessed 21 Dec 2020
Géléoc GGS, El-Amraoui A. Disease mechanisms and gene therapy for Usher syndrome. Hear Res. 2020;394
El-Amraoui A, Petit C. The retinal phenotype of Usher syndrome: pathophysiological insights from animal models. Comptes Rendus Biol. 2014;337:167–77. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/24702843/. Accessed 1 Mar 2021
Mathur P, Yang J. Usher syndrome: hearing loss, retinal degeneration and associated abnormalities. Biochim Biophys Acta Mol Basis Dis. 2015;1852:406–20. Available at: https://doi.org/10.1016/j.bbadis.2014.11.020.
Geng R, Melki S, Chen DHC, et al. The mechanosensory structure of the hair cell requires clarin-1, a protein encoded by Usher syndrome III causative gene. J Neurosci. 2012;32:9485–98. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/22787034/. Accessed 1 Mar 2021
Chen HY, Kelley RA, Li T, Swaroop A. Primary cilia biogenesis and associated retinal ciliopathies. Scdb. 2020. Available at: https://doi.org/10.1016/j.semcdb.2020.07.013.
Reiter JF, Leroux MR. Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol. 2017;18:533–47. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851292/?report=abstract. Accessed 26 Dec 2020.
Farag TI, Teebi AS. High incidence of Bardet Biedl syndrome among the Bedouin. Clin Genet. 1989;36:463–4. Available at: https://pubmed.ncbi.nlm.nih.gov/2591073/. Accessed 27 Dec 2020
Green JS, Parfrey PS, Harnett JD, et al. The cardinal manifestations of Bardet–Biedl syndrome, a form of Laurence–Moon–Biedl syndrome. N Engl J Med. 1989;321:1002–9. Available at: https://pubmed.ncbi.nlm.nih.gov/2779627/. Accessed 27 Dec 2020
Klein D, Ammann F. The syndrome of Laurence-Moon-Bardet-Biedl and allied diseases in Switzerland. Clinical, genetic and epidemiological studies. J Neurol Sci. 1969;9:479–513. Available at: https://pubmed.ncbi.nlm.nih.gov/5367041/. Accessed 7 Feb 2021
Schachat AP, Maumenee IH. Bardet-Biedl syndrome and related disorders. Arch Ophthalmol. 1982;100:285–8. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/7065946/. Accessed 28 Dec 2020
Zacchia M, Di Iorio V, Trepiccione F, et al. The kidney in Bardet-Biedl syndrome: possible pathogenesis of urine concentrating defect. Kidney Dis. 2017;3:57–65. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/28868293/. Accessed 1 Mar 2021
Elbedour K, Zucker N, Zalzstein E, et al. Cardiac abnormalities in the Bardet-Biedl syndrome: echocardiographic studies of 22 patients. Am J Med Genet. 1994;52:164–9. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/7802002/. Accessed 28 Dec 2020
Anon. RetNet—Retinal Information Network. Available at: https://sph.uth.edu/retnet/. Accessed 9 Feb 2016.
Tsang SH, Aycinena ARP, Sharma T. Ciliopathy: Bardet-Biedl syndrome. In: Advances in experimental medicine and biology. Vol 1085. New York: Springer; 2018. p. 171–4.
Satta M, Castro-Sánchez S, Valverde D. Bardet-Biedl syndrome as a chaperonopathy: dissecting the major role of chaperonin-like BBS proteins (BBS6-BBS10-BBS12). Front Mol Biosci. 2017;4:55. Available at: www.frontiersin.org.
Zaghloul NA, Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest. 2009;119:428–37.
Niederlova V, Modrak M, Tsyklauri O, et al. Meta-analysis of genotype-phenotype associations in Bardet-Biedl syndrome uncovers differences among causative genes. Hum Mutat. 2019;40:2068–87.
Senior B, Friedmann AI, Braudo JL. Juvenile familial nephropathy with tapetoretinal degeneration. A new oculorenal dystrophy. Am J Ophthalmol. 1961;52:625–33. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/13910672/. Accessed 25 Feb 2021
Tsang SH, Aycinena ARP, Sharma T. Ciliopathy: Senior-Løken syndrome. In: Advances in experimental medicine and biology. Vol 1085. New York: Springer; 2018. p. 175–8.
Luo F, Tao YH. Nephronophthisis: a review of genotype–phenotype correlation. Nephrology. 2018;23:904–11. Available at: https://pubmed.ncbi.nlm.nih.gov/29717526/. Accessed 1 Mar 2021
Ronquillo CC, Bernstein PS, Baehr W. Senior-Løken syndrome: a syndromic form of retinal dystrophy associated with nephronophthisis. Vis Res. 2012;75:88–97.
Wang SF, Kowal TJ, Ning K, et al. Review of ocular manifestations of Joubert syndrome. Genes (Basel). 2018;9. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/30518138/. Accessed 23 Dec 2020
Westfall JE, Hoyt C, Liu Q, et al. Retinal degeneration and failure of photoreceptor outer segment formation in mice with targeted deletion of the Joubert syndrome gene, Ahi1. J Neurosci. 2010;30:8759–68. Available at: https://pubmed.ncbi.nlm.nih.gov/20592197/. Accessed 26 Feb 2021
Mitchell E, Gilbert M, Loomes KM. Alagille syndrome. Clin Liver Dis. 2018;22:625–41. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/30266153/. Accessed 1 Mar 2021
Kohlschütter A, Schulz A, Bartsch U, Storch S. Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs. 2019;33:315–25. Available at: https://doi.org/10.1007/s40263-019-00620-8. Accessed 28 Dec 2020.
Claussen M, Heim P, Knispel J, et al. Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet. 1992;42:536–8. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/1609834/. Accessed 28 Dec 2020
Goebel HH. The neuronal ceroid-lipofuscinoses. Semin Pediatr Neurol. 1996;3:270–8.
Arsenio-Nunes ML, Goutières F, Aicardi J. An ultramicroscopic study of skin and conjunctival biopsies in chronic neurological disorders of childhood. Ann Neurol. 1981;9:163–73. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/7235631/. Accessed 1 Mar 2021
Poll-The BT, Saudubray JM, Ogier H, et al. Infantile Refsum’s disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 1986;9:169–74. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/2427795/. Accessed 28 Feb 2021
Kumar R, De Jesus O. Refsum disease. StatPearls; 2021. Available at: http://www.ncbi.nlm.nih.gov/pubmed/32809453. Accessed 28 Feb 2021.
Jansen GA, Ofman R, Ferdinandusse S, et al. Refsum disease is caused by mutations in the phytanoyl-coa hydroxylase gene. Nat Genet. 1997;17:193. Available at: https://pubmed.ncbi.nlm.nih.gov/9326940/. Accessed 29 Dec 2020
Jansen GA, Waterham HR, Wanders RJA. Molecular basis of refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum Mutat. 2004;23:209–18. Available at: https://pubmed.ncbi.nlm.nih.gov/14974078/. Accessed 29 Dec 2020
Rüether K, Baldwin E, Casteels M, et al. Adult refsum disease: a form of tapetoretinal dystrophy accessible to therapy. Surv Ophthalmol. 2010;55:531–8. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/20850855/. Accessed 28 Feb 2021
Kisilevsky E, Freund P, Margolin E. Mitochondrial disorders and the eye. Surv Ophthalmol. 2020;65:294–311. Available at: https://doi.org/10.1016/j.survophthal.2019.11.001.
Schaefer AM, McFarland R, Blakely EL, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 2008;63:35–9. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/17886296/. Accessed 28 Feb 2021
Yatsuga S, Povalko N, Nishioka J, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta Gen Subj. 1820;2012:619–24. Available at: http://lps3.pubmed.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/21443929/. Accessed 1 Mar 2021
Agier V, Auré K, Lombès A. MELAS syndrome. Drugs Future. 2009;34:237–41. Available at: http://lps3.www.ncbi.nlm.nih.gov.libproxy.snu.ac.kr/books/NBK532959/. Accessed 1 Mar 2021
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yoon, C.K. (2022). Syndromic Retinitis Pigmentosa. In: Yu, HG. (eds) Inherited Retinal Disease. Springer, Singapore. https://doi.org/10.1007/978-981-16-7337-5_5
Download citation
DOI: https://doi.org/10.1007/978-981-16-7337-5_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-7336-8
Online ISBN: 978-981-16-7337-5
eBook Packages: MedicineMedicine (R0)